The PERSEVERE Study (NCT06588634)

🧪 Interventions in This Study

• FlowTriever System (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (29 Sites)

Showing the first 25 of 29 sites.

• Yale University — New Haven, Connecticut
• AdventHealth Orlando — Orlando, Florida
• Orlando Health Regional Medical Center — Orlando, Florida
• Sarasota Memorial Hospital — Sarasota, Florida
• Emory University — Atlanta, Georgia
• University of Mississippi Medical Center — Jackson, Mississippi
• Northwell Health — Bay Shore, New York
• SUNY, The University at Buffalo — Buffalo, New York
• Summa Akron — Akron, Ohio
• UPHS Penn Health System — Philadelphia, Pennsylvania
• UPMC — Pittsburgh, Pennsylvania
• Allegheny General Hospital — Pittsburgh, Pennsylvania
• HCA Tristar/Centennial — Nashville, Tennessee
• HCA Medical City Heart & Spine — Dallas, Texas
• HCA Methodist Health San Antonio — San Antonio, Texas
• Besançon University Hospital — Besançon,
• CHU Grenoble Alpes — La Tronche,
• Hopital Arnaud de Villeneuve, Montpellier — Montpellier,
• CHU Nîmes Caremeau — Nîmes,
• Hôpital Européen Georges-Pompidou, Paris — Paris,
• Klinikum Chemnitz — Chemnitz,
• Universitätsklinikum Carl Gustav Carus an der TU Dresden — Dresden,
• Universitätsmedizin Mainz — Mainz,
• Munich LMU — München,
• Universitätsklinik Regensburg — Regensburg,

📞 Contact the Study Coordinator

Phone: +32 476 53 88 05

Email: tine.devolder@stryker.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Pulmonary Embolism

• Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Birmingham, Alabama
• Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial — Phoenix, Arizona
• Comparing Electrical Impedance Tomography to Computed Tomographic Angiography — Loveland, Colorado
• Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE — Bay Shore, New York
• Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE) — Ann Arbor, Michigan
• Pulmonary Embolism International THrOmbolysis Study-3 — Linz,

Explore by condition: All Pulmonary Embolism clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.